- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02134145
Scanadu Consumer Health Outcomes (SCOUT) Study (SCOUT)
Usability Study of the Scanadu Scout
There is a great need within healthcare to develop systems of care that better engage and activate people in their own care before they become patients. By so doing lay users will be empowered to take charge of their own care in recognizing they can change their health and improve their quality of life. Mobile health technologies such as the Scanadu ScoutTM hold the potential to truly engage individuals in the way needed through real-time data capture, transmission and connectivity.
We propose to evaluate the real-world use of the Scanadu ScoutTM by a cohort of self-selected investors in an earlier crowdfunding campaign on Indiegogo for the Scanadu Scout™, through a prospective observational study. Using validated survey tools and through the remote tracking of frequency of use and physiological measurements from the Scanadu Scout™ device and app.
Participants will receive web-based surveys at 4 time points: baseline, 3, 12 and 18 months.
Participants will be instructed to use the Scanadu Scout™ as much as they would like. The parameters that will be functional on the device and available for measurement by the participant are:
- Heart rate
- Respiratory rate
- Temperature
- Oxygen saturation
- Heart rate variability
- Blood pressure
Data analysis will examine individual participant and aggregate level:
- Usage and physiologic measurement data of the device,
- Perceptions of the device, and
- Changes in self-reported health self-management, health-related quality of life, participant- physician communication and medication adherence between baseline and follow-up.
Descripción general del estudio
Estado
Condiciones
Descripción detallada
We propose to evaluate the real-world use of the Scanadu ScoutTM by a cohort of self-selected investors in an earlier crowdfunding campaign on Indiegogo for the Scanadu Scout™, through a prospective observational study. Using validated survey tools and through the remote tracking of frequency of use and physiological measurements from the Scanadu Scout™ device and app, this study will provide preliminary evidence for:
- Level of engagement and impact of Scanadu ScoutTM on health behavior with a focus on potential risks and safety.
- Long term (up to 18 months) recurrent usage rate of the various physiologic measurements linked to users and survey data.
- Ease of use and acceptance of the Scanadu ScoutTM technology.
This study will utilize a longitudinal cohort design. All Scanadu Scout investors (~5000 individuals) will be invited to participate in the study prior to receiving their Scanadu Scout™. Potential participants will receive a link to an online study platform. The platform will contain the Informed Consent form and all the study materials. After a participant reads and signs the Consent the participant will be enrolled in the study and a Scanadu Scout™ device will be sent. The participant will download the Scanadu Scout™ app from the App Stores (iOS/Android). The app will require a handshake with a Scanadu Scout™ device before it becomes fully functional to limit access to study participants.
After signing the Informed Consent form the participant will be asked to complete baseline surveys to assess participant characteristics, health self-management and health-related quality of life prior to using the Scanadu Scout™. At 3 months, 12 months, and at 18 months, a participant will be asked to complete Health Self-Management and Health-Related QOL surveys as well as an additional assessment of their perceptions of the device. Backers who do not wish to partake in this study will not receive the device and will be entitled to get their contribution back.
Participants will be instructed to use the device as much as they would like over the course of the study. The parameters that will be functional on the device and available for measurement by the participant are:
- Heart rate
- Respiratory rate
- Temperature
- Oxygen saturation
- Heart rate variability
- Blood pressure
Data analysis will examine individual participant and aggregate level:
- Usage and physiologic measurement data of the device,
- Perceptions of the device, and
- Changes in self-reported health self-management, health-related quality of life, participant- physician communication and medication adherence between baseline and follow-up.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
California
-
La Jolla, California, Estados Unidos, 92037
- Scripps Translational Science Institute
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Over 18 years of age
- Signed Informed Consent Form
Exclusion Criteria:
- None
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
---|
Self Selected Investors
A self selected crowdfunding backers from teh Scanadu Scout Crowdfunding campaign.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Participant Characteristics
Periodo de tiempo: Baseline
|
|
Baseline
|
Changes in psychological outcomes as measured by:
Periodo de tiempo: Baseline, 3 months, 12 months, and 18 months
|
a. Anxiety Levels (Speilberger State-Trait Anxiety Inventory; STAI Y-6 item)
|
Baseline, 3 months, 12 months, and 18 months
|
Changes in Health Outcomes as measured by:
Periodo de tiempo: Baseline, 3 months, 12 months, and 18 months
|
|
Baseline, 3 months, 12 months, and 18 months
|
Changes in Lifestyle Outcomes as measured by:
Periodo de tiempo: 3 months, 12 months, and 18 months
|
|
3 months, 12 months, and 18 months
|
Perceptions of the Scanadu Scout™ as measured by
Periodo de tiempo: 3 months, 12 months, and 18 months
|
|
3 months, 12 months, and 18 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Steven Steinhubl, MD, STSI
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- Scanadu
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .